Pritesh Shah, Chief Commercial Officer at NovoCure Ltd (NVCR), sold 56,642 shares at $86.07 ($4.8M) on 2020-09-09, disclosed to the SEC on 2020-09-11.
Open-market sale of $4.8M NVCR by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.39 | 27,621 | $2.4M | 48.8% |
| 2 | $85.39 | 27,621 | $2.4M | 48.8% |
| 3 | $86.07 | 700 | $60K | 1.2% |
| 4 | $86.07 | 700 | $60K | 1.2% |
| Total | $85.41 avg | 56,642 | $4.8M | 100% |
| Filing → |
| NVCR | SELL | 2023-03-07 | $3.3M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $141K | — | Filing → |
| NVCR | SELL | 2023-03-02 | $294K | — | Filing → |